Self-aggregated nanoparticles of cholesterol-modified glycol chitosan conjugate: Preparation, characterization, and preliminary assessment as a new drug delivery carrier

Jing-Mou Yu,Yong-Jie Li,Li-Yan Qiu,Yi Jin
DOI: https://doi.org/10.1016/j.eurpolymj.2008.01.013
IF: 6
2008-01-01
European Polymer Journal
Abstract:Cholesterol-modified glycol chitosan (CHGC) conjugate was synthesized and characterized by FTIR and 1H NMR. The degree of substitution (DS) was 6.7 cholesterol groups per 100 sugar residues of glycol chitosan. CHGC formed self-aggregated nanoparticles with a roughly spherical shape and a mean diameter of 228nm by probe sonication in aqueous medium. The physicochemical properties of the self-aggregated nanoparticles were studied using dynamic light scattering (DLS), transmission electron microscopy (TEM) and fluorescence spectroscopy. The critical aggregation concentration (CAC) of self-aggregated nanoparticles in aqueous solution was 0.1223mg/mL. Indomethacin (IND), as a model drug, was physically entrapped into the CHGC nanoparticles by dialysis method. The characteristics of IND-loaded CHGC (IND–CHGC) nanoparticles was analyzed using DLS, TEM and high performance liquid chromatography (HPLC). The IND–CHGC nanoparticles were almost spherical in shape and their size increased from 275 to 384nm with the IND-loading content increasing from 7.14% to 16.2%. The in vitro release behavior of IND from CHGC nanoparticles was studied by a dialysis method in phosphate buffered saline (PBS, pH 7.4). IND was released in a biphasic way. The initial rapid release in 2h and slower release for up to 12h were observed. The results indicated that CHGC nanoparticles had a potential as a drug delivery carrier.
What problem does this paper attempt to address?